BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29076211)

  • 1. What is the best size predictor for dose in the obese child?
    Anderson BJ; Holford NH
    Paediatr Anaesth; 2017 Dec; 27(12):1176-1184. PubMed ID: 29076211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine pharmacokinetics in the obese.
    Cortínez LI; Anderson BJ; Holford NH; Puga V; de la Fuente N; Auad H; Solari S; Allende FA; Ibacache M
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1501-8. PubMed ID: 26407689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for Intravenous Anesthesia Dose in Obese Children: Understanding PKPD.
    Morse JD; Cortinez LI; Anderson BJ
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Acetaminophen Dosing in Obese Children.
    Anderson BJ; Cortinez LI
    Children (Basel); 2023 Mar; 10(4):. PubMed ID: 37189874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.
    Sinha J; Duffull SB; Green B; Al-Sallami HS
    Clin Pharmacokinet; 2020 Apr; 59(4):475-483. PubMed ID: 31583612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allometric size: The scientific theory and extension to normal fat mass.
    Holford NHG; Anderson BJ
    Eur J Pharm Sci; 2017 Nov; 109S():S59-S64. PubMed ID: 28552478
    [No Abstract]   [Full Text] [Related]  

  • 7. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthesia in the obese patient: pharmacokinetic considerations.
    Casati A; Putzu M
    J Clin Anesth; 2005 Mar; 17(2):134-45. PubMed ID: 15809132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetaminophen pharmacokinetics in severely obese adolescents and young adults.
    Hakim M; Anderson BJ; Walia H; Tumin D; Michalsky MP; Syed A; Tobias JD
    Paediatr Anaesth; 2019 Jan; 29(1):20-26. PubMed ID: 30484909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
    Cortínez LI; Anderson BJ; Penna A; Olivares L; Muñoz HR; Holford NH; Struys MM; Sepulveda P
    Br J Anaesth; 2010 Oct; 105(4):448-56. PubMed ID: 20710020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standard weight descriptor for dose adjustment in the obese patient.
    Duffull SB; Dooley MJ; Green B; Poole SG; Kirkpatrick CM
    Clin Pharmacokinet; 2004; 43(15):1167-78. PubMed ID: 15568893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in pharmacokinetic modeling: target controlled infusions in the obese.
    Cortínez LI; Anderson BJ
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):415-422. PubMed ID: 29794852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the best size descriptor to use for pharmacokinetic studies in the obese?
    Green B; Duffull SB
    Br J Clin Pharmacol; 2004 Aug; 58(2):119-33. PubMed ID: 15255794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing dilemmas in obese children.
    Mulla H; Johnson TN
    Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of body composition on bone mineral content in children and adolescents.
    Manzoni P; Brambilla P; Pietrobelli A; Beccaria L; Bianchessi A; Mora S; Chiumello G
    Am J Clin Nutr; 1996 Oct; 64(4):603-7. PubMed ID: 8839506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach.
    Hulens M; Vansant G; Lysens R; Claessens AL; Muls E; Brumagne S
    Int J Obes Relat Metab Disord; 2001 May; 25(5):676-81. PubMed ID: 11360150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
    Tanvig M
    Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative pharmacology in morbid obesity.
    Lemmens HJ
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):485-91. PubMed ID: 20531173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.